Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Cleveland OH, Pittsburgh PA, Ann Arbor MI, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase2, Phase3, Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for
Advanced Solid Tumors, HER2 Mutation
Location: Cleveland OH, Toronto, Nashville TN, Boston MA,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06760819
Phase2, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: Cleveland OH, Saint Clair Shores MI, Detroit MI,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
New
VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)
for
Ascites, Variceal Bleeding,
Location: Cleveland OH, Atlanta GA, Minneapolis MN
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07390344
Recruiting
New
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
for
Ulcerative Colitis, Inflammatory Bowel Diseases,
Location: Cleveland OH, Roswell GA, Tampa FL, Miami FL
Sponsor: Athos Therapeutics Inc
Sex: All
Age: 18 - 70+
Code: NCT07513181
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
for
Alcohol Use Disorder (AUD), Alcohol Related Liver Disease
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07824089
Recruiting
New
NIRAF-camera Versus Conventional Surgery in Preoperative Imaging Negative Primary Hyperparathyroidism
for
Primary Hyperparathyroidism
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07812649
Recruiting
New
Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
Evaluation of 4D Intracardiac Echocardiography (ICE) During Structural Heart and Electrophysiology Procedures
for
Atrial Fibrillation
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT07806890
Recruiting
Personalized Real-Time DBS and PD Mechanisms
for
Parkinson Disease
Location: Cleveland OH
Sponsor: David Escobar
Sex: All
Age: 18 - 70+
Code: NCT06013956
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Cleveland OH, Canton OH, London, Toronto, Columbia MD,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase3, Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: Cleveland OH, Charleston WV, York PA, Baltimore MD,
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase3, Recruiting
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Cleveland OH, New York NY, Rochester MN,
Sponsor: GI Innovation, Inc.
Sex: All
Age: 18+
Code: NCT05824975
Phase1, Phase2, Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM